Expert Ratings for BioNTech
Portfolio Pulse from Benzinga Insights
BioNTech (NASDAQ:BNTX) has received 6 bullish and 7 indifferent ratings from analysts in the last quarter. The average price target is $148.23, representing an upside from the current price of $109.51. This average price target is a 6.33% decrease from the previous average of $158.25.
July 14, 2023 | 1:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BioNTech has received mostly bullish and indifferent ratings from analysts, with an average price target of $148.23, indicating potential upside.
The majority of the analysts have given bullish or indifferent ratings to BioNTech, indicating a positive or neutral outlook. The average price target is higher than the current price, suggesting potential upside. However, the decrease in the average price target from the previous quarter could indicate a slightly less optimistic outlook.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100